Let's spread the word about Immunotherapy! Click to share this page with your community.

Seventh Annual Immuno-Oncology 360°

Samik Upadhaya, Ph.D., research analyst, is speaking on the “Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies” virtual panel session on February 25 at 2:45 PM ET.

IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

The 7th Annual Immuno-Oncology 360° Delivers Three Key Benefits:

Access to KOLs driving the science
Partnership opportunities with all stakeholders in Immuno-Oncology
Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology

2021 Key Topic Areas

  • Discovery/Preclinical Science
  • Cell & Gene Therapy
  • Translational Science
  • Bispecifics
  • Clinical Developments
  • Neoadjuvant/Adjuvant Data
  • Emerging Biomarkers
  • Vaccines
  • Clinical Operations
  • AI & Machine Learning
  • Imaging Advancements
  • Business Developments


*Immunotherapy results may vary from patient to patient.